Clathrin, Light Chain A (CLTA) (C-Term) Peptide
Quick Overview for Clathrin, Light Chain A (CLTA) (C-Term) Peptide (ABIN975096)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- KELEEWYARQ DEQLQKTKAN NRAAEEAFVN DIDESSPGTE WERVARLCDF
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-CLTA Antibody(ARP59458_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CLTA (Clathrin, Light Chain A (CLTA))
-
Background
-
Clathrin is a large, soluble protein composed of heavy and light chains. It functions as the main structural component of the lattice-type cytoplasmic face of coated pits and vesicles which entrap specific macromolecules during receptor-mediated endocytosis. This gene encodes one of two clathrin light chain proteins which are believed to function as regulatory elements. Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 8 and 12.
Alias Symbols: LCA
Protein Size: 218 -
Molecular Weight
- 24 kDa
-
Gene ID
- 1211
-
NCBI Accession
- NM_001833, NP_001824
-
UniProt
- P09496
Target
-